Bronte Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$7.05M |
| 2 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$4.45M |
| 3 |
Herbalife
HLF
|
+$2.96M |
| 4 |
Bath & Body Works
BBWI
|
+$2.72M |
| 5 |
Sotera Health
SHC
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$16.4M |
| 2 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$3.44M |
| 3 |
Albemarle
ALB
|
+$3.28M |
| 4 |
Newmont
NEM
|
+$3.14M |
| 5 |
Corteva
CTVA
|
+$2.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.09% |
| 2 | Communication Services | 18.52% |
| 3 | Healthcare | 13.51% |
| 4 | Consumer Staples | 12.7% |
| 5 | Materials | 9.19% |
Similar funds
Bronte Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bronte Capital Management held 33 positions worth $803M, down 8% from $873M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Bronte Capital Management withdrew a net $64.7M in Q3 2022, closing 5 positions and reducing 13 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $16.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Bronte Capital Management opened a new position in Riskified worth $1.75M.
- Bronte Capital Management's largest Q3 2022 buy was Riskified: 443,480 shares worth $1.75M.
- Bronte Capital Management added most to Activision Blizzard in Q3 2022, an estimated $7.05M increase.
- Bronte Capital Management's biggest Q3 2022 reduction was Albemarle, cutting an estimated $3.28M.
- Bronte Capital Management fully exited Meta Platforms (Facebook) in Q3 2022, selling an estimated $16.4M.
- Bronte Capital Management's ten largest holdings make up 80% of its $803M portfolio in Q3 2022.
- Bronte Capital Management opened 1 new position and closed 5 in Q3 2022.
- Bronte Capital Management's portfolio value fell 8% quarter-over-quarter to $803M.
Based on Bronte Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.